Schizophrenia Drugs Market to Reach Valuation US$8.04 bn by 2023

The latest trending report published by Crystal Market Research titled, Schizophrenia Drugs Market, approximates that the Schizophrenia Drugs market size is estimated to flourish at a significant CAGR in the future, and this is attributed to the escalation in need for this product across the globe along with novel innovations in the market.

Get Sample Copy of the Report here: https://www.crystalmarketresearch.com/report-sample/HC12414

Key Players in Market:

  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Dainippon Sumitomo Pharma Co Ltd
  • Vanda Pharma
  • Johnson & Johnson
  • Alkermes
  • Allergan and AstraZeneca. Johnson & Johnson
  • Otsuka
  • Lundbeck

Rising number of patients looking for treatment and rising interest for enhanced healthcare infrastructure are foreseen to drive the market. The schizophrenia market stays packed with solid neglected needs. There is a requirement for advancement for the treatment of this crippling disorder. The report examines about developing markets in the Asia Pacific region. India and China are rising as an open door for market extension. Factors, for example, useful medicinal services, increased health awareness, large aging population, and low-cost are the real driving variables for market extension in these two nations.

The Schizophrenia Drugs Market was worth USD 6.35 billion in the year of 2014 and is expected to reach approximately USD 8.04 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 2.65% during the forecast period.

Access Complete Report: https://www.crystalmarketresearch.com/report/schizophrenia-drugs-market

The Schizophrenia Drugs Market is segmented as follows-

By Therapeutic Class:

  • Second-Generation Antipsychotics
    • Invega (Paliperidone)
    • Geodon (Ziprasidone)
    • Latuda (Lurasidone)
    • Fanapt (Iloperidone)
    • Vraylar (Cariprazine)
    • Risperdal (Risperidone)
    • Zyprexa (Olanzapine)
    • Seroquel (Quetiapine)
    • Aristada (Aripiprazole Lauroxil)
    • Saphris (Asenapine)
  • Third-Generation Antipsychotics
    • Abilify (Aripiprazole)
  • Others
    • Generics
    • First-Generation Antipsychotics

Speak to Experts for any Queries: https://www.crystalmarketresearch.com/send-an-enquiry/HC12414

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:

Email: sales@crystalmarketresearch.com

Website: http://www.crystalmarketresearch.com

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: